Details of the Drug

General Information of Drug (ID: DMAO869)

Drug Name

AGN-214868

Synonyms

SXN-100323; SXN-323; Cell secretion inhibitors (pain), Syntaxin/Allergan; Modified bacterial protein therapies (pain), Allergan/Syntaxin; Clostridial endopeptidase-based compounds (pain), Allergan/Syntaxin; Neurotoxin-based technology (pain), CAMR/Allergan

Indication

Disease Entry	ICD 11	Status	REF
Overactive bladder	GC50.0	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D02PNP

References

1	ClinicalTrials.gov (NCT01678924) A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia. U.S. National Institutes of Health.